These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18425322)

  • 1. Genetic polymorphisms and head and neck cancer risk (Review).
    Hiyama T; Yoshihara M; Tanaka S; Chayama K
    Int J Oncol; 2008 May; 32(5):945-73. PubMed ID: 18425322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms and esophageal cancer risk.
    Hiyama T; Yoshihara M; Tanaka S; Chayama K
    Int J Cancer; 2007 Oct; 121(8):1643-58. PubMed ID: 17674367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of genetic factors on the incidence of multiple primary tumors (MPT) of the head and neck.
    Rydzanicz M; Wierzbicka M; Gajecka M; Szyfter W; Szyfter K
    Cancer Lett; 2005 Jun; 224(2):263-78. PubMed ID: 15914277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression.
    Duarte EC; Ribeiro DC; Gomez MV; Ramos-Jorge ML; Gomez RS
    Anticancer Res; 2008; 28(2A):1101-6. PubMed ID: 18507060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism in cytochrome P4501A1 is significantly associated with head and neck cancer risk.
    Singh AP; Shah PP; Ruwali M; Mathur N; Pant MC; Parmar D
    Cancer Invest; 2009 Oct; 27(8):869-76. PubMed ID: 19639480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsomal epoxide hydrolase genotypes and the risk for head and neck cancer.
    Lacko M; Roelofs HM; Te Morsche RH; Voogd AC; Oude Ophuis MB; Peters WH; Manni JJ
    Head Neck; 2008 Jul; 30(7):836-44. PubMed ID: 18383527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 2E1 and head and neck cancer: interaction with genetic and environmental risk factors.
    Ruwali M; Khan AJ; Shah PP; Singh AP; Pant MC; Parmar D
    Environ Mol Mutagen; 2009 Jul; 50(6):473-82. PubMed ID: 19334053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population.
    Saxena A; Dhillon VS; Raish M; Asim M; Rehman S; Shukla NK; Deo SV; Ara A; Husain SA
    Breast Cancer Res Treat; 2009 Jun; 115(3):537-43. PubMed ID: 18574688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association studies of CYP1A1 and GSTM1 polymorphisms with esophageal cancer risk: evidence-based meta-analyses.
    Zhuo WL; Zhang YS; Wang Y; Zhuo XL; Zhu B; Cai L; Chen ZT
    Arch Med Res; 2009 Apr; 40(3):169-79. PubMed ID: 19427967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy.
    Huang ZH; Hua D; Du X
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):1001-7. PubMed ID: 19247656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms of smoking-related carcinogen detoxifying enzymes and head and neck cancer susceptibility.
    Lacko M; Oude Ophuis MB; Peters WH; Manni JJ
    Anticancer Res; 2009 Feb; 29(2):753-61. PubMed ID: 19331232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms and head and neck cancer outcomes: a review.
    Hopkins J; Cescon DW; Tse D; Bradbury P; Xu W; Ma C; Wheatley-Price P; Waldron J; Goldstein D; Meyer F; Bairati I; Liu G
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):490-9. PubMed ID: 18349267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
    Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
    J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
    Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
    Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures.
    Saadat M; Ansari-Lari M
    Breast Cancer Res Treat; 2009 May; 115(1):137-44. PubMed ID: 18481169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of glutathione S-transferase T1, M1 and P1 genotypes and breast cancer risk.
    Unlü A; Ates NA; Tamer L; Ates C
    Cell Biochem Funct; 2008; 26(5):643-7. PubMed ID: 18521819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer.
    Boccia S; Boffetta P; Brennan P; Ricciardi G; Gianfagna F; Matsuo K; van Duijn CM; Hung RJ
    Cancer Lett; 2009 Jan; 273(1):55-61. PubMed ID: 18789576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review.
    Mo Z; Gao Y; Cao Y; Gao F; Jian L
    Prostate; 2009 May; 69(6):662-88. PubMed ID: 19143011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XRCC1 polymorphism and lung cancer risk.
    Schneider J; Classen V; Helmig S
    Expert Rev Mol Diagn; 2008 Nov; 8(6):761-80. PubMed ID: 18999926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Review and Meta-Analysis of the Relationship between EPHX1 Polymorphisms and the Risk of Head and Neck Cancer.
    Chen H; Ge L; Sui Q; Lin M
    PLoS One; 2015; 10(4):e0123347. PubMed ID: 25923690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.